Identification and characterization of RanBPM, a novel coactivator of thyroid hormone receptors.

Thyroid hormone receptors (TRs) are transcription factor members of the nuclear receptor superfamily. The transcriptional activity of TRs is controlled by thyroid hormones and cell-specific coregulators. Using the yeast two-hybrid system, we identified RanBPM as a new protein partner for TRs. RanBPM was initially discovered as an interacting partner for Ran, and was also shown to be a protein partner and coactivator of the androgen receptor. The novel interaction between RanBPM and TR isoforms was addressed by glutathione-S-transferase (GST) pull-down assays and co-immunoprecipitation in intact mammalian cells, where RanBPM was shown to bind TRs in a ligand-independent fashion. We also studied the regions implicated in the interaction with deletion mutants: the principal interacting region of RanBPM is comprised within its carboxyl-terminal end and the TR DNA-binding domain is sufficient to mediate the interaction. To investigate the potential role of RanBPM in thyroid hormone action, transient transfections with luciferase reporter genes were performed in CV-1 cells. We found that the over-expression of RanBPM increases the activation of TRETK- and DR+4-positive thyroid hormone response elements. Interestingly, over-expression of the truncated protein RanBPM55, which lacks the N-terminal polyglutaminated region but binds TRs, decreased the fold activation by almost 80%. Furthermore, we performed competition assays using transient transfection of RanBPM and increasing amounts of RanBPM55. This revealed that the stimulating effect on TR transactivation by the full-length protein is inhibited in a dose-dependent fashion by RanBPM55. This suggests that although the polyglutaminated region of RanBPM is not required for the binding to TRs, it is required for the stimulation of TR transactivation. Taken together, our results provide evidence that RanBPM is a potent novel coactivator for thyroid hormone receptors.

[1]  M. Langlois,et al.  General receptor for phosphoinositides 1, a novel repressor of thyroid hormone receptor action that prevents deoxyribonucleic acid binding. , 2005, Molecular endocrinology.

[2]  V. Lemmon,et al.  RanBPM is an L1‐interacting protein that regulates L1‐mediated mitogen‐activated protein kinase activation , 2005, Journal of neurochemistry.

[3]  O. Hermanson,et al.  A specific role for the TFIID subunit TAF4 and RanBPM in neural progenitor differentiation , 2005, Molecular and Cellular Neuroscience.

[4]  T. Gibson,et al.  The C terminus of fragile X mental retardation protein interacts with the multi-domain Ran-binding protein in the microtubule-organising centre. , 2004, Journal of molecular biology.

[5]  D. Bai,et al.  RanBPM is a novel binding protein for p75NTR. , 2003, Biochemical and biophysical research communications.

[6]  Jianming Xu,et al.  Review of the in vivo functions of the p160 steroid receptor coactivator family. , 2003, Molecular endocrinology.

[7]  J. Wong,et al.  Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators. , 2003, Molecular endocrinology.

[8]  J. Wong,et al.  A role for cofactor–cofactor and cofactor–histone interactions in targeting p300, SWI/SNF and Mediator for transcription , 2003, The EMBO journal.

[9]  D. Wirtz,et al.  A mechanism of coupling RCC1 mobility to RanGTP production on the chromatin in vivo , 2003, The Journal of cell biology.

[10]  P. Rennie,et al.  RanBPM, a Nuclear Protein That Interacts with and Regulates Transcriptional Activity of Androgen Receptor and Glucocorticoid Receptor* , 2002, The Journal of Biological Chemistry.

[11]  A. M. Masini-Repiso,et al.  Differential modulation of liver and pituitary triiodothyronine and 9-cis retinoid acid receptors by insulin-like growth factor I in rats. , 2002, Thyroid : official journal of the American Thyroid Association.

[12]  E. Messing,et al.  Activation of Ras/Erk Pathway by a Novel MET-interacting Protein RanBPM* , 2002, The Journal of Biological Chemistry.

[13]  Josephine C. Adams.  Characterization of a Drosophila melanogaster orthologue of muskelin. , 2002, Gene.

[14]  L. Laflamme,et al.  RXR acts as a coregulator in the regulation of genes of the hypothalamo-pituitary axis by thyroid hormone receptors. , 2002, Journal of molecular endocrinology.

[15]  D. Edwards,et al.  Jun Dimerization Protein 2 Functions as a Progesterone Receptor N-Terminal Domain Coactivator , 2002, Molecular and Cellular Biology.

[16]  E. Fliers,et al.  TRβ1 Protein Is Preferentially Expressed in the Pericentral Zone of Rat Liver and Exhibits Marked Diurnal Variation. , 2002, Endocrinology.

[17]  W. Chin,et al.  Identification and Characterization of a Tissue-Specific Coactivator, GT198, That Interacts with the DNA-Binding Domains of Nuclear Receptors , 2022 .

[18]  B. E. Black,et al.  DNA binding domains in diverse nuclear receptors function as nuclear export signals , 2001, Current Biology.

[19]  T Nishimoto,et al.  Full-sized RanBPM cDNA encodes a protein possessing a long stretch of proline and glutamine within the N-terminal region, comprising a large protein complex. , 2001, Gene.

[20]  P. Yen,et al.  Physiological and molecular basis of thyroid hormone action. , 2001, Physiological reviews.

[21]  H. Samuels,et al.  PSF Is a Novel Corepressor That Mediates Its Effect through Sin3A and the DNA Binding Domain of Nuclear Hormone Receptors , 2001, Molecular and Cellular Biology.

[22]  G. Hager,et al.  Trafficking of nuclear receptors in living cells , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  R. Lanz,et al.  Nuclear receptor coregulators: cellular and molecular biology. , 1999, Endocrine reviews.

[24]  R. Roeder,et al.  Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Takashi Miyata,et al.  When Overexpressed, a Novel Centrosomal Protein, RanBPM, Causes Ectopic Microtubule Nucleation Similar to γ-Tubulin , 1998, The Journal of cell biology.

[26]  Y. Liu,et al.  Thyroid Hormone Response Elements Differentially Modulate the Interactions of Thyroid Hormone Receptors with Two Receptor Binding Domains in the Steroid Receptor Coactivator-1* , 1998, The Journal of Biological Chemistry.

[27]  N. Koibuchi,et al.  TRAM-1, A Novel 160-kDa Thyroid Hormone Receptor Activator Molecule, Exhibits Distinct Properties from Steroid Receptor Coactivator-1* , 1997, The Journal of Biological Chemistry.

[28]  F. Wondisford,et al.  A unique role of the beta-2 thyroid hormone receptor isoform in negative regulation by thyroid hormone. Mapping of a novel amino-terminal domain important for ligand-independent activation. , 1997, The Journal of biological chemistry.

[29]  F. B. Davis,et al.  Protein synthesis-dependent potentiation by thyroxine of antiviral activity of interferon-gamma. , 1997, The American journal of physiology.

[30]  P Bork,et al.  SPRY domains in ryanodine receptors (Ca(2+)-release channels). , 1997, Trends in biochemical sciences.

[31]  Erich A. Nigg,et al.  Nucleocytoplasmic transport: signals, mechanisms and regulation , 1997, Nature.

[32]  B. Howard,et al.  A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A , 1996, Nature.

[33]  T. Nagaya,et al.  Second zinc finger mutants of thyroid hormone receptor selectively preserve DNA binding and heterodimerization but eliminate transcriptional activation. , 1996, Biochemical and biophysical research communications.

[34]  B. O’Malley,et al.  Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.

[35]  Thorsten Heinzel,et al.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.

[36]  R. Evans,et al.  A transcriptional co-repressor that interacts with nuclear hormone receptors , 1995, Nature.

[37]  T. Nishimoto,et al.  RanBP1, a Ras-like nuclear G protein binding to Ran/TC4, inhibits RCC1 via Ran/TC4 , 1995, Molecular and General Genetics MGG.

[38]  P. Chambon,et al.  The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full‐length receptors to direct repeats. , 1994, The EMBO journal.

[39]  V K Chatterjee,et al.  Negative regulation of the thyroid-stimulating hormone alpha gene by thyroid hormone: receptor interaction adjacent to the TATA box. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[41]  R. Evans,et al.  The c-erb-A gene encodes a thyroid hormone receptor , 1986, Nature.

[42]  B. A. Harris,et al.  Plasmids for the cloning and expression of full-length double-stranded cDNAs under control of the SV40 early or late gene promoter. , 1983, Nucleic acids research.

[43]  F. B. Davis,et al.  Protein synthesis-dependent potentiation by thyroxine of antiviral activity of interferon-γ. , 1997, American journal of physiology. Cell physiology.